3-Factor Versus 4-Factor PCC in Coagulopathy of Trauma: Four is Better Than Three

Muhammad Zeeshan, Mohammad Hamidi, Narong Kulvatunyou, Faisal Jehan, Terence O'Keeffe, Muhammad Khan, Lana Rashdan, Andrew Tang, El Rasheid Zakaria, Bellal Joseph

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: Coagulopathy of trauma (COT) is common and highly lethal. Prothrombin complex concentrate (PCC) has been advocated for correction of COT. However, the difference in efficacy between three-factor PCC (3-PCC) versus four-factor PCC (4-PCC) remains unclear. The aim of our study was to compare efficacy of 3-PCC versus 4-PCC in COT. METHODS: Five-year (2013-2017) review of coagulopathic trauma patients at our Level-I trauma center who received 3- or 4-PCC. Patients were divided into two groups (4-PCC and 3-PCC) and matched in 1:1 ratio using propensity-score-matching for demographics, injury parameters, admission vitals, and hematological parameters. Primary outcomes were time to correction of international normalized ratio (INR), blood products transfusion, thromboembolic complications, and mortality. Secondary outcomes were hospital-length of stay (LOS), intensive care unit (ICU)-LOS, cost of therapy, and total hospital cost. RESULTS: Six hundred fifty-seven patients met inclusion criteria of whom 250 patients (4-PCC:125; 3-PCC:125) were matched. The mean age was 50 ± 19.4 y, 64% were male, and median-injury severity score was 24[15-33]. 4-PCC was associated with accelerated correction of INR (365 vs. 428 min, P = 0.01), decrease in red blood cells (7 units vs. 10 units, P = 0.04) and FFP (6 units vs. 8 units, P = 0.03) transfused. There was no difference in platelet transfusion, thromboembolic complications, mortality, hospital, and ICU-LOS. 4-PCC was associated with higher cost of PCC therapy, and lower cost of transfusion. There was no difference regarding the total hospital cost between the two groups. CONCLUSION: Compared with 3-factor PCC, the use of 4-factor PCC is associated with a rapid reversal of INR and reduction in transfusion requirement without increasing the overall hospital cost or the risk of thromboembolic events. 4-PCC may be preferred as an adjunct for the resuscitation of coagulopathic trauma patients.

Original languageEnglish (US)
Pages (from-to)23-28
Number of pages6
JournalShock (Augusta, Ga.)
Volume52
Issue number1
DOIs
StatePublished - Jul 1 2019

Fingerprint

Wounds and Injuries
International Normalized Ratio
Hospital Costs
Length of Stay
prothrombin complex concentrates
Costs and Cost Analysis
Intensive Care Units
Platelet Transfusion
Propensity Score
Injury Severity Score
Trauma Centers
Hospital Mortality
Resuscitation
Blood Transfusion
Erythrocytes
Demography
Mortality
Therapeutics

ASJC Scopus subject areas

  • Emergency Medicine
  • Critical Care and Intensive Care Medicine

Cite this

3-Factor Versus 4-Factor PCC in Coagulopathy of Trauma : Four is Better Than Three. / Zeeshan, Muhammad; Hamidi, Mohammad; Kulvatunyou, Narong; Jehan, Faisal; O'Keeffe, Terence; Khan, Muhammad; Rashdan, Lana; Tang, Andrew; Zakaria, El Rasheid; Joseph, Bellal.

In: Shock (Augusta, Ga.), Vol. 52, No. 1, 01.07.2019, p. 23-28.

Research output: Contribution to journalArticle

Zeeshan, M, Hamidi, M, Kulvatunyou, N, Jehan, F, O'Keeffe, T, Khan, M, Rashdan, L, Tang, A, Zakaria, ER & Joseph, B 2019, '3-Factor Versus 4-Factor PCC in Coagulopathy of Trauma: Four is Better Than Three', Shock (Augusta, Ga.), vol. 52, no. 1, pp. 23-28. https://doi.org/10.1097/SHK.0000000000001240
Zeeshan, Muhammad ; Hamidi, Mohammad ; Kulvatunyou, Narong ; Jehan, Faisal ; O'Keeffe, Terence ; Khan, Muhammad ; Rashdan, Lana ; Tang, Andrew ; Zakaria, El Rasheid ; Joseph, Bellal. / 3-Factor Versus 4-Factor PCC in Coagulopathy of Trauma : Four is Better Than Three. In: Shock (Augusta, Ga.). 2019 ; Vol. 52, No. 1. pp. 23-28.
@article{a05ef69d90f54856955af15022167e13,
title = "3-Factor Versus 4-Factor PCC in Coagulopathy of Trauma: Four is Better Than Three",
abstract = "INTRODUCTION: Coagulopathy of trauma (COT) is common and highly lethal. Prothrombin complex concentrate (PCC) has been advocated for correction of COT. However, the difference in efficacy between three-factor PCC (3-PCC) versus four-factor PCC (4-PCC) remains unclear. The aim of our study was to compare efficacy of 3-PCC versus 4-PCC in COT. METHODS: Five-year (2013-2017) review of coagulopathic trauma patients at our Level-I trauma center who received 3- or 4-PCC. Patients were divided into two groups (4-PCC and 3-PCC) and matched in 1:1 ratio using propensity-score-matching for demographics, injury parameters, admission vitals, and hematological parameters. Primary outcomes were time to correction of international normalized ratio (INR), blood products transfusion, thromboembolic complications, and mortality. Secondary outcomes were hospital-length of stay (LOS), intensive care unit (ICU)-LOS, cost of therapy, and total hospital cost. RESULTS: Six hundred fifty-seven patients met inclusion criteria of whom 250 patients (4-PCC:125; 3-PCC:125) were matched. The mean age was 50 ± 19.4 y, 64{\%} were male, and median-injury severity score was 24[15-33]. 4-PCC was associated with accelerated correction of INR (365 vs. 428 min, P = 0.01), decrease in red blood cells (7 units vs. 10 units, P = 0.04) and FFP (6 units vs. 8 units, P = 0.03) transfused. There was no difference in platelet transfusion, thromboembolic complications, mortality, hospital, and ICU-LOS. 4-PCC was associated with higher cost of PCC therapy, and lower cost of transfusion. There was no difference regarding the total hospital cost between the two groups. CONCLUSION: Compared with 3-factor PCC, the use of 4-factor PCC is associated with a rapid reversal of INR and reduction in transfusion requirement without increasing the overall hospital cost or the risk of thromboembolic events. 4-PCC may be preferred as an adjunct for the resuscitation of coagulopathic trauma patients.",
author = "Muhammad Zeeshan and Mohammad Hamidi and Narong Kulvatunyou and Faisal Jehan and Terence O'Keeffe and Muhammad Khan and Lana Rashdan and Andrew Tang and Zakaria, {El Rasheid} and Bellal Joseph",
year = "2019",
month = "7",
day = "1",
doi = "10.1097/SHK.0000000000001240",
language = "English (US)",
volume = "52",
pages = "23--28",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - 3-Factor Versus 4-Factor PCC in Coagulopathy of Trauma

T2 - Four is Better Than Three

AU - Zeeshan, Muhammad

AU - Hamidi, Mohammad

AU - Kulvatunyou, Narong

AU - Jehan, Faisal

AU - O'Keeffe, Terence

AU - Khan, Muhammad

AU - Rashdan, Lana

AU - Tang, Andrew

AU - Zakaria, El Rasheid

AU - Joseph, Bellal

PY - 2019/7/1

Y1 - 2019/7/1

N2 - INTRODUCTION: Coagulopathy of trauma (COT) is common and highly lethal. Prothrombin complex concentrate (PCC) has been advocated for correction of COT. However, the difference in efficacy between three-factor PCC (3-PCC) versus four-factor PCC (4-PCC) remains unclear. The aim of our study was to compare efficacy of 3-PCC versus 4-PCC in COT. METHODS: Five-year (2013-2017) review of coagulopathic trauma patients at our Level-I trauma center who received 3- or 4-PCC. Patients were divided into two groups (4-PCC and 3-PCC) and matched in 1:1 ratio using propensity-score-matching for demographics, injury parameters, admission vitals, and hematological parameters. Primary outcomes were time to correction of international normalized ratio (INR), blood products transfusion, thromboembolic complications, and mortality. Secondary outcomes were hospital-length of stay (LOS), intensive care unit (ICU)-LOS, cost of therapy, and total hospital cost. RESULTS: Six hundred fifty-seven patients met inclusion criteria of whom 250 patients (4-PCC:125; 3-PCC:125) were matched. The mean age was 50 ± 19.4 y, 64% were male, and median-injury severity score was 24[15-33]. 4-PCC was associated with accelerated correction of INR (365 vs. 428 min, P = 0.01), decrease in red blood cells (7 units vs. 10 units, P = 0.04) and FFP (6 units vs. 8 units, P = 0.03) transfused. There was no difference in platelet transfusion, thromboembolic complications, mortality, hospital, and ICU-LOS. 4-PCC was associated with higher cost of PCC therapy, and lower cost of transfusion. There was no difference regarding the total hospital cost between the two groups. CONCLUSION: Compared with 3-factor PCC, the use of 4-factor PCC is associated with a rapid reversal of INR and reduction in transfusion requirement without increasing the overall hospital cost or the risk of thromboembolic events. 4-PCC may be preferred as an adjunct for the resuscitation of coagulopathic trauma patients.

AB - INTRODUCTION: Coagulopathy of trauma (COT) is common and highly lethal. Prothrombin complex concentrate (PCC) has been advocated for correction of COT. However, the difference in efficacy between three-factor PCC (3-PCC) versus four-factor PCC (4-PCC) remains unclear. The aim of our study was to compare efficacy of 3-PCC versus 4-PCC in COT. METHODS: Five-year (2013-2017) review of coagulopathic trauma patients at our Level-I trauma center who received 3- or 4-PCC. Patients were divided into two groups (4-PCC and 3-PCC) and matched in 1:1 ratio using propensity-score-matching for demographics, injury parameters, admission vitals, and hematological parameters. Primary outcomes were time to correction of international normalized ratio (INR), blood products transfusion, thromboembolic complications, and mortality. Secondary outcomes were hospital-length of stay (LOS), intensive care unit (ICU)-LOS, cost of therapy, and total hospital cost. RESULTS: Six hundred fifty-seven patients met inclusion criteria of whom 250 patients (4-PCC:125; 3-PCC:125) were matched. The mean age was 50 ± 19.4 y, 64% were male, and median-injury severity score was 24[15-33]. 4-PCC was associated with accelerated correction of INR (365 vs. 428 min, P = 0.01), decrease in red blood cells (7 units vs. 10 units, P = 0.04) and FFP (6 units vs. 8 units, P = 0.03) transfused. There was no difference in platelet transfusion, thromboembolic complications, mortality, hospital, and ICU-LOS. 4-PCC was associated with higher cost of PCC therapy, and lower cost of transfusion. There was no difference regarding the total hospital cost between the two groups. CONCLUSION: Compared with 3-factor PCC, the use of 4-factor PCC is associated with a rapid reversal of INR and reduction in transfusion requirement without increasing the overall hospital cost or the risk of thromboembolic events. 4-PCC may be preferred as an adjunct for the resuscitation of coagulopathic trauma patients.

UR - http://www.scopus.com/inward/record.url?scp=85067809674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067809674&partnerID=8YFLogxK

U2 - 10.1097/SHK.0000000000001240

DO - 10.1097/SHK.0000000000001240

M3 - Article

C2 - 30074978

AN - SCOPUS:85067809674

VL - 52

SP - 23

EP - 28

JO - Shock

JF - Shock

SN - 1073-2322

IS - 1

ER -